Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001.
Nussenzveig RH, Cortes J, Sever M, Quintás-Cardama A, Ault P, Manshouri T, Bueso-Ramos C, Prchal JT, Kantarjian H, Verstovsek S.
Nussenzveig RH, et al. Among authors: prchal jt.
Int J Hematol. 2009 Jul;90(1):58-63. doi: 10.1007/s12185-009-0345-y. Epub 2009 May 30.
Int J Hematol. 2009.
PMID: 19484334
Free PMC article.
Clinical Trial.